Research Grade Arevirumab-3

Catalog No.

DVV04301

Expression system

Mammalian Cells

Species reactivity

Lassa virus (strain Mouse/Sierra Leone/Josiah/1976) (LASV)

Host species

Human

Isotype

IgG1-kappa

Clonality

Monoclonal

Target

GPC

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P08669

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Arevirumab-3

Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex., PMID:39013466

Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus., PMID:38280377

Monoclonal antibody therapy demonstrates increased virulence of a lineage VII strain of Lassa virus in nonhuman primates., PMID:38164768

A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus., PMID:37590417

Contemporary and emerging pharmacotherapeutic agents for the treatment of Lassa viral haemorrhagic fever disease., PMID:35296886

Antibody therapy for Lassa fever., PMID:31401518

Document Download

Research Grade Arevirumab-3.pdf